Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial von Dearnaley, David, Prof, Syndikus, Isabel, MD, Mossop, Helen, MMathStat, Khoo, Vincent, MD, Birtle, Alison, FRCR, Bloomfield, David, FRCR, Graham, John, FRCR, Kirkbride, Peter, FRCR, Logue, John, FRCR, Malik, Zafar, FRCR, Money-Kyrle, Julian, FRCR, O'Sullivan, Joe M, Prof, Panades, Miguel, MRCR, Parker, Chris, FRCR, Patterson, Helen, FRCR, Scrase, Christopher, FRCR, Staffurth, John, MD, Stockdale, Andrew, FRCR, Tremlett, Jean, MSc, Bidmead, Margaret, MSc, Mayles, Helen, MSc, Naismith, Olivia, MSc, South, Chris, PhD, Gao, Annie, MSc, Cruickshank, Clare, BSc[Hons], Hassan, Shama, MSc, Pugh, Julia, CIM Dip, Griffin, Clare, MSc, Hall, Emma, PhD

Volltext

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, plat... von James, Nicholas D, Prof, Sydes, Matthew R, MSc, Clarke, Noel W, Prof, Mason, Malcolm D, Prof, Dearnaley, David P, Prof, Spears, Melissa R, MSc, Ritchie, Alastair W S, MD, Parker, Christopher C, MD, Russell, J Martin, FRCR, Attard, Gerhardt, MD PhD, de Bono, Johann, Prof, Cross, William, PhD, Jones, Rob J, Prof, Thalmann, George, Prof, Amos, Claire, PhD, Matheson, David, PhD, Millman, Robin, Alzouebi, Mymoona, FRCR, Beesley, Sharon, FRCR, Birtle, Alison J, MD, Brock, Susannah, FRCR, Cathomas, Richard, MD, Chakraborti, Prabir, FRCR, Chowdhury, Simon, MD, Cook, Audrey, FRCR, Elliott, Tony, PhD, Gale, Joanna, DM, Gibbs, Stephanie, FRCR, Graham, John D, FRCP, Hetherington, John, FRCS[Eng], Hughes, Robert, FRCR, Laing, Robert, FRCR, McKinna, Fiona, FRCR, McLaren, Duncan B, FRCR, FRCP[Ed], O'Sullivan, Joe M, Prof, Parikh, Omi, FRCR, Peedell, Clive, FRCR, Protheroe, Andrew, PhD, Robinson, Angus J, FRCR, Srihari, Narayanan, MD, Srinivasan, Rajaguru, FRCR, Staffurth, John, MD, Sundar, Santhanam, FRCR, Tolan, Shaun, MD, Tsang, David, MCRP, Wagstaff, John, Prof, Parmar, Mahesh K B, Prof

Volltext

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial von Saad, Fred, Prof, Carles, Joan, MD, Gillessen, Silke, Prof, Heidenreich, Axel, Prof, Heinrich, Daniel, MD, Gratt, Jeremy, BA, Lévy, Jérémy, ScD, Miller, Kurt, Prof, Nilsson, Sten, Prof, Petrenciuc, Oana, MD, Tucci, Marcello, MD, Wirth, Manfred, Prof, Federhofer, Judith, MD, O'Sullivan, Joe M, Prof

Volltext

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespe... von Hoskin, Peter, Prof, Sartor, Oliver, Prof, O'Sullivan, Joe M, Prof, Johannessen, Dag Clement, MD, Helle, Svein I, MD, Logue, John, FRCR, Bottomley, David, FRCR, Nilsson, Sten, Prof, Vogelzang, Nicholas J, Prof, Fang, Fang, PhD, Wahba, Mona, MD, Aksnes, Anne-Kirsti, PhD, Parker, Christopher, MD

Volltext

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, rand... von Sartor, Oliver, Prof, Coleman, Robert, Prof, Nilsson, Sten, Prof, Heinrich, Daniel, MD, Helle, Svein I, MD, O'Sullivan, Joe M, Prof, Fosså, Sophie D, Prof, Chodacki, Aleš, MD, Wiechno, Paweł, MD, Logue, John, FRCR, Widmark, Anders, Prof, Johannessen, Dag Clement, MD, Hoskin, Peter, Prof, James, Nicholas D, Prof, Solberg, Arne, MD, Syndikus, Isabel, FRCR, Vogelzang, Nicholas J, Prof, O'Bryan-Tear, C Gillies, MRCP, Shan, Minghua, PhD, Bruland, Øyvind S, Prof, Parker, Christopher, MD

Volltext

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program von Heidenreich, Axel, Gillessen, Silke, Heinrich, Daniel, Keizman, Daniel, O'Sullivan, Joe M, Carles, Joan, Wirth, Manfred, Miller, Kurt, Reeves, John, Seger, Monica, Nilsson, Sten, Saad, Fred

Volltext

Use of bisphosphonates and other bone supportive agents in the management of prostate cancer—A UK perspective von Payne, Heather, Bahl, Amit, O’Sullivan, Joe M.

Volltext

Fiducial marker guided prostate radiotherapy: a review von O'Neill, Angela G M, Jain, Suneil, Hounsell, Alan R, O'Sullivan, Joe M

Volltext

Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy von McMahon, Stephen J, Hyland, Wendy B, Muir, Mark F, Coulter, Jonathan A, Jain, Suneil, Butterworth, Karl T, Schettino, Giuseppe, Dickson, Glenn R, Hounsell, Alan R, O’Sullivan, Joe M, Prise, Kevin M, Hirst, David G, Currell, Fred J

Volltext

Integrating radium-223 therapy into the management of metastatic prostate cancer care: a plain language summary von O'Sullivan, Joe M, Abramowitz, Elliot, Sierra-Scacalossi, Len

Volltext

Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor... von Brown, Malcolm, Murphy, Marie H., McAneney, Helen, McBride, Ken, Crawford, Ffiona, Cole, Aidan, O’Sullivan, Joe M., Jain, Suneil, Prue, Gillian

Volltext

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two random... von Attard, Gerhardt, Murphy, Laura, Sachdeva, Ashwin, Jones, Craig, Hoyle, Alex, Cross, William, Parker, Christopher C, Cook, Adrian, Gilson, Clare, Rush, Hannah, Abdel-Aty, Hoda, Amos, Claire L, Murphy, Claire, Chowdhury, Simon, Malik, Zafar, Parkar, Nazia, Pugh, Cheryl, Pezaro, Carmel, Grant, Warren, Saxby, Helen, Birtle, Alison, Thomas, Carys, Tanguay, Jacob, Parikh, Omi, Cathomas, Richard, Brown, Michael D, Jain, Yatin, Dearnaley, David P, Mason, Malcolm D, Millman, Robin, Sydes, Matthew R, Parmar, Mahesh K B, James, Nicholas D, Hyde, Katherine, Glen, Hilary, McGovern, Ursula, Beresford, Mark, Malik, Zafar, Lee, Ling, Sreenivasan, Thiagarajan, Brock, Sue, Brown, Simon, Smith-Howell, Mike, Phan, Mau-Don, Narahari, Krishna, Tanguay, Jacob, Douglas, Fiona, Kumar, Anil, Simms, Matthew, Worlding, Jane, Tran, Anna, Pezaro, Carmel, Sivoglo, Virgil, Masters, Benjamin, Manetta, Caroline, McLaren, Duncan, Taylor, Henry, Perna, Carla, Melcher, Lucinda, Grant, Warren, Dealey, Robert, McPhail, Neil, Brierly, Robert, Sidek, Norma, Whelan, Peter, Robson, Peter, Falconer, Alison, Rudman, Sarah, Vivekanandan, Sindu, Mullessey, Vinod, Vilarino-Varela, Maria, Khoo, Vincent, Sangar, Vijay, Hoskin, Peter, Mullassery, Viwod, Sundar, Santhanam, Khan, Yakhub, Conroy, Ruth, Carser, Judith, Rogers, Paul, Tarver, Kathryn, Gibbs, Stephanie, Khan, Mohammad Muneeb, Hingorani, Mohan, Alameddine, Manal, Hughes, Robert, Logue, John, Vengalil, Salil, Khan, Omar, Ahmed, Imtiaz, Nikapota, Ashok, Bloomfield, David, Rentsch, Cyrill, Pereira Mestre, Ricardo, Roggero, Enrico, Borner, Markus, Berthold, Dominik, Engeler, Daniel, John, Hubert, Popescu, Razvan

Volltext

Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial von Rush, Hannah L, Murphy, Laura, Morgans, Alicia K, Clarke, Noel W, Cook, Adrian D, Attard, Gerhardt, Macnair, Archie, Dearnaley, David P, Parker, Christopher C, Russell, J Martin, Gillessen, Silke, Matheson, David, Millman, Robin, Brawley, Christopher D, Pugh, Cheryl, Tanguay, Jacob S, Jones, Robert J, Wagstaff, John, Rudman, Sarah, O'Sullivan, Joe M, Gale, Joanna, Birtle, Alison, Protheroe, Andrew, Gray, Emma, Perna, Carla, Tolan, Shaun, McPhail, Neil, Malik, Zaf I, Vengalil, Salil, Fackrell, David, Hoskin, Peter, Sydes, Matthew R, Chowdhury, Simon, Gilbert, Duncan C, Parmar, Mahesh K B, James, Nicholas D, Langley, Ruth E

Volltext

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the... von Wilkins, Anna, FRCR, Mossop, Helen, MMathStat, Syndikus, Isabel, FRCR, Khoo, Vincent, MD, Bloomfield, David, FRCR, Parker, Chris, FRCR, Logue, John, FRCR, Scrase, Christopher, FRCR, Patterson, Helen, FRCR, Birtle, Alison, FRCR, Staffurth, John, MD, Malik, Zafar, FRCR, Panades, Miguel, MRCR, Eswar, Chinnamani, FRCR, Graham, John, FRCR, Russell, Martin, FRCR, Kirkbride, Peter, FRCR, O'Sullivan, Joe M, Prof, Gao, Annie, MSc, Cruickshank, Clare, BSc (Hons), Griffin, Clare, MSc, Dearnaley, David, Prof, Hall, Emma, Dr

Volltext

Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis von McCourt, Clare M, McArt, Darragh G, Mills, Ken, Catherwood, Mark A, Maxwell, Perry, Waugh, David J, Hamilton, Peter, O'Sullivan, Joe M, Salto-Tellez, Manuel

Volltext

Computed Tomography-based Radiomics for Risk Stratification in Prostate Cancer von Osman, Sarah O.S., Leijenaar, Ralph T.H., Cole, Aidan J., Lyons, Ciara A., Hounsell, Alan R., Prise, Kevin M., O'Sullivan, Joe M., Lambin, Philippe, McGarry, Conor K., Jain, Suneil

Volltext

A kinetic-based model of radiation-induced intercellular signalling von McMahon, Stephen J, Butterworth, Karl T, Trainor, Colman, McGarry, Conor K, O'Sullivan, Joe M, Schettino, Giuseppe, Hounsell, Alan R, Prise, Kevin M

Volltext

Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study von O'Sullivan, Joe M, Heinrich, Daniel, Castro, Elena, George, Saby, Dizdarevic, Sabina, Baldari, Sergio, Essler, Markus, Jong, Igle Jan de, Lastoria, Secondo, Hammerer, Peter G, Tombal, Bertrand, James, Nicholas D, Meltzer, Jeff, Sandström, Per, Sartor, Oliver

Volltext

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease von Bolla, Michel, Neven, Anouk, Maingon, Philippe, Carrie, Christian, Boladeras, Ana, Andreopoulos, Demetrios, Engelen, Antoine, Sundar, Santhanam, van der Steen-Banasik, Elzbieta M., Armstrong, John, Peignaux-Casasnovas, Karine, Boustani, Jihane, Herrera, Fernanda G., Pieters, Bradley R., Slot, Annerie, Bahl, Amit, Scrase, Christopher D., Azria, David, Jansa, Jan, O'Sullivan, Joe M., Van Den Bergh, Alphonsus C. M., Collette, Laurence

Volltext

Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles von Coulter, Jonathan A, Jain, Suneil, Butterworth, Karl T, Taggart, Laura E, Dickson, Glenn R, McMahon, Stephen J, Hyland, Wendy B, Muir, Mark F, Trainor, Coleman, Hounsell, Alan R, O'Sullivan, Joe M, Schettino, Giuseppe, Currell, Fred J, Hirst, David G, Prise, Kevin M

Volltext